Lindbrook Capital, LLC Ngm Biopharmaceuticals Inc Transaction History

Lindbrook Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 26, 2023	BUY	$3.72 - $5.4 $859 - $1,247	231 Added 22.06%	1,278 $5,000
Q4 2022 Jan 24, 2023	BUY	$3.41 - $12.93 $2,953 - $11,197	866 Added 478.45%	1,047 $0
Q3 2022 Nov 10, 2022	SELL	$12.59 - $17.67 $528 - $742	-42 Reduced 18.83%	181 $2,000
Q2 2022 Aug 01, 2022	BUY	$10.58 - $17.5 $931 - $1,540	88 Added 65.19%	223 $3,000
Q1 2022 Apr 21, 2022	BUY	$13.81 - $18.6 $883 - $1,190	64 Added 90.14%	135 $2,000
Q1 2020 Apr 22, 2020	SELL	$10.0 - $19.51 $10 - $19	-1 Reduced 1.39%	71 $1,000
Q4 2019 Jan 27, 2020	BUY	$9.97 - $20.28 $717 - $1,460	72 New	72 $1,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.